Nov Santé Actions Non Cotées Fund completed the acquisition of a minority stake in Oncodesign Services for €22m.

Nov Santé Actions Non Cotées Fund, a private equity firm, completed the acquisition of a minority stake in Oncodesign Services, a French pre-clinical drug discovery and research company specializing in oncology and immuno-inflammation, for €22m. “The outsourcing of pharmaceutical research services is a fundamental trend around the world. To ensure that we are self-reliant in healthcare, it is vital that we keep leading players in this field within France and Europe,” Arnaud Vincent, Nov Santé Actions Non Cotées Fund, Managing Director.